Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD'. Together they form a unique fingerprint.

Medicine & Life Sciences